Vesamicol Receptor Mapping of Brain Cholinergic Neurons with Radioiodine- Labeled Positional Isomers of Benzovesamicol
Alzheimer's disease is characterized by progressive cerebral cholinergic neuronal degeneration. Radiotracer analogs of benzovesamicol, which bind with high affinity to the vesamicol receptor located on the uptake transporter of acetylcholine storage vesicles, may provide an in vivo marker of ch...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 1996-08, Vol.39 (17), p.3331-3342 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3342 |
---|---|
container_issue | 17 |
container_start_page | 3331 |
container_title | Journal of medicinal chemistry |
container_volume | 39 |
creator | Jung, Yong-Woon Frey, Kirk A Mulholland, G. Keith del Rosario, Renato Sherman, Phillip S Raffel, David M Van Dort, Marcian E Kuhl, David E Gildersleeve, David L Wieland, Donald M |
description | Alzheimer's disease is characterized by progressive cerebral cholinergic neuronal degeneration. Radiotracer analogs of benzovesamicol, which bind with high affinity to the vesamicol receptor located on the uptake transporter of acetylcholine storage vesicles, may provide an in vivo marker of cholinergic neuronal integrity. Five positional isomers of racemic iodobenzovesamicol (4‘-, 5-, 6-, 7-, and 8-IBVM) were synthesized, exchange-labeled with iodine-125, and evaluated as possible in vivo markers for central cholinergic neurons. Only two isomers, 5-IBVM (5) and 6-IBVM (10), gave distribution patterns in mouse brain consistent with cholinergic innervation: striatum ≫ hippocampus ≥ cortex > hypothalamus ≫ cerebellum. The 24-h tissue-to-cerebellum concentration ratios for 5-IBVM (5) were 3−4-fold higher for striatum, cortex, and hippocampus than the respective ratios for 6-IBVM (10). Neither 8-IBVM (16) nor 4‘-IBVM (17) exhibited selective retention in any of the brain regions examined. In the heart, only 5-IBVM (5) exhibited an atria-to-ventricles concentration ratio consistent with high peripheral cholinergic neuronal selectivity. The 7-IBVM (14) isomer exhibited an anomalous brain distribution pattern, marked by high and prolonged retention in the five brain regions, most notably the cerebellum. This isomer was screened for binding in a series of 26 different biological assays; 7-IBVM (14) exhibited affinity only for the σ-receptor with an IC50 of ∼30 nM. Drug-blocking studies suggested that brain retention of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors. Competitive binding studies using rat cortical homogenates gave IC50 values for binding to the vesamicol receptor of 2.5 nM for 5-IBVM (5), 4.8 nM for 6-IBVM (10), and 3.5 nM for 7-IBVM (14). Ex vivo autoradiography of rat brain after injection of (−)-5-[125I]IBVM ((−)-[125I]5) clearly delineated small cholinergic-rich areas such as basolateral amygdala, interpeduncular nucleus, and facial nuclei. Except for cortex, regional brain levels of (−)-5-[123I]IBVM ((−)-[123I]5) at 4 h exhibited a linear correlation (r = 0.99) with endogenous levels of choline acetyltransferase. Conclusion: Vesamicol receptor mapping of cholinergic nerve terminals in murine brain can be achieved with 5-IBVM (5) and less robustly with 6-IBVM (10), whereas the brain localization of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors. |
doi_str_mv | 10.1021/jm9507486 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78264566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15682844</sourcerecordid><originalsourceid>FETCH-LOGICAL-a410t-d24b53407c2854c39a54286856289eb800f52acf0143b606d9e6433648dcb4163</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EKtvCgR-A5AMgcQiMP-M9wopCpQWqsiDExXIcp_WSxMGTlI9fT8oue0LiNIfn0TujeQl5wOAZA86eb7ulglIafYssmOJQSAPyNlkAcF5wzcVdcoy4BQDBuDgiR6bUSrFyQa4_BXRd9KmlF8GHYUyZvnXDEPtLmhr6MrvY09VVamMf8mX09F2YcuqRfo_jFb1wdUwx1TMs6NpVoQ01PU8Yx5h619IzTF3I-Ccp9L_S9d9l98idxrUY7u_nCfl4-mqzelOs378-W71YF04yGIuay0oJCaXnRkkvlk5JbrRRmptlqAxAo7jzDTApKg26XgYthdDS1L6STIsT8mSXO-T0bQo42i6iD23r-pAmtKXhWir9f5EpbbiRchaf7kSfE2IOjR1y7Fz-aRnYmzLsoYzZfbgPnaou1Adz__2ZP9pzh961TXa9j3jQBDNSMDVrxU6LOIYfB-zyV6tLUSq7Of9gvwjY8M-G2Zu1j3e-82i3acpzFfiP834D7VOrNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15682844</pqid></control><display><type>article</type><title>Vesamicol Receptor Mapping of Brain Cholinergic Neurons with Radioiodine- Labeled Positional Isomers of Benzovesamicol</title><source>MEDLINE</source><source>ACS Publications</source><creator>Jung, Yong-Woon ; Frey, Kirk A ; Mulholland, G. Keith ; del Rosario, Renato ; Sherman, Phillip S ; Raffel, David M ; Van Dort, Marcian E ; Kuhl, David E ; Gildersleeve, David L ; Wieland, Donald M</creator><creatorcontrib>Jung, Yong-Woon ; Frey, Kirk A ; Mulholland, G. Keith ; del Rosario, Renato ; Sherman, Phillip S ; Raffel, David M ; Van Dort, Marcian E ; Kuhl, David E ; Gildersleeve, David L ; Wieland, Donald M</creatorcontrib><description>Alzheimer's disease is characterized by progressive cerebral cholinergic neuronal degeneration. Radiotracer analogs of benzovesamicol, which bind with high affinity to the vesamicol receptor located on the uptake transporter of acetylcholine storage vesicles, may provide an in vivo marker of cholinergic neuronal integrity. Five positional isomers of racemic iodobenzovesamicol (4‘-, 5-, 6-, 7-, and 8-IBVM) were synthesized, exchange-labeled with iodine-125, and evaluated as possible in vivo markers for central cholinergic neurons. Only two isomers, 5-IBVM (5) and 6-IBVM (10), gave distribution patterns in mouse brain consistent with cholinergic innervation: striatum ≫ hippocampus ≥ cortex > hypothalamus ≫ cerebellum. The 24-h tissue-to-cerebellum concentration ratios for 5-IBVM (5) were 3−4-fold higher for striatum, cortex, and hippocampus than the respective ratios for 6-IBVM (10). Neither 8-IBVM (16) nor 4‘-IBVM (17) exhibited selective retention in any of the brain regions examined. In the heart, only 5-IBVM (5) exhibited an atria-to-ventricles concentration ratio consistent with high peripheral cholinergic neuronal selectivity. The 7-IBVM (14) isomer exhibited an anomalous brain distribution pattern, marked by high and prolonged retention in the five brain regions, most notably the cerebellum. This isomer was screened for binding in a series of 26 different biological assays; 7-IBVM (14) exhibited affinity only for the σ-receptor with an IC50 of ∼30 nM. Drug-blocking studies suggested that brain retention of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors. Competitive binding studies using rat cortical homogenates gave IC50 values for binding to the vesamicol receptor of 2.5 nM for 5-IBVM (5), 4.8 nM for 6-IBVM (10), and 3.5 nM for 7-IBVM (14). Ex vivo autoradiography of rat brain after injection of (−)-5-[125I]IBVM ((−)-[125I]5) clearly delineated small cholinergic-rich areas such as basolateral amygdala, interpeduncular nucleus, and facial nuclei. Except for cortex, regional brain levels of (−)-5-[123I]IBVM ((−)-[123I]5) at 4 h exhibited a linear correlation (r = 0.99) with endogenous levels of choline acetyltransferase. Conclusion: Vesamicol receptor mapping of cholinergic nerve terminals in murine brain can be achieved with 5-IBVM (5) and less robustly with 6-IBVM (10), whereas the brain localization of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm9507486</identifier><identifier>PMID: 8765517</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Alzheimer Disease - pathology ; Alzheimer Disease - physiopathology ; Animals ; Autoradiography ; Binding, Competitive ; Biological and medical sciences ; Brain - cytology ; Brain - metabolism ; Brain - physiology ; Brain Mapping ; Cholinergic system ; Female ; Guinea Pigs ; Humans ; Iodine Radioisotopes ; Isomerism ; Medical sciences ; Mice ; Mice, Inbred Strains ; Neuromuscular Depolarizing Agents - chemical synthesis ; Neuromuscular Depolarizing Agents - metabolism ; Neurons - cytology ; Neurons - metabolism ; Neurons - physiology ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Organ Specificity ; Pharmacology. Drug treatments ; Piperidines - chemical synthesis ; Piperidines - metabolism ; Rats ; Rats, Sprague-Dawley ; Receptors, Cholinergic - analysis ; Tetrahydronaphthalenes - chemical synthesis ; Tetrahydronaphthalenes - metabolism</subject><ispartof>Journal of medicinal chemistry, 1996-08, Vol.39 (17), p.3331-3342</ispartof><rights>Copyright © 1996 American Chemical Society</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a410t-d24b53407c2854c39a54286856289eb800f52acf0143b606d9e6433648dcb4163</citedby><cites>FETCH-LOGICAL-a410t-d24b53407c2854c39a54286856289eb800f52acf0143b606d9e6433648dcb4163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm9507486$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm9507486$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2751,27055,27903,27904,56716,56766</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3184315$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8765517$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jung, Yong-Woon</creatorcontrib><creatorcontrib>Frey, Kirk A</creatorcontrib><creatorcontrib>Mulholland, G. Keith</creatorcontrib><creatorcontrib>del Rosario, Renato</creatorcontrib><creatorcontrib>Sherman, Phillip S</creatorcontrib><creatorcontrib>Raffel, David M</creatorcontrib><creatorcontrib>Van Dort, Marcian E</creatorcontrib><creatorcontrib>Kuhl, David E</creatorcontrib><creatorcontrib>Gildersleeve, David L</creatorcontrib><creatorcontrib>Wieland, Donald M</creatorcontrib><title>Vesamicol Receptor Mapping of Brain Cholinergic Neurons with Radioiodine- Labeled Positional Isomers of Benzovesamicol</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Alzheimer's disease is characterized by progressive cerebral cholinergic neuronal degeneration. Radiotracer analogs of benzovesamicol, which bind with high affinity to the vesamicol receptor located on the uptake transporter of acetylcholine storage vesicles, may provide an in vivo marker of cholinergic neuronal integrity. Five positional isomers of racemic iodobenzovesamicol (4‘-, 5-, 6-, 7-, and 8-IBVM) were synthesized, exchange-labeled with iodine-125, and evaluated as possible in vivo markers for central cholinergic neurons. Only two isomers, 5-IBVM (5) and 6-IBVM (10), gave distribution patterns in mouse brain consistent with cholinergic innervation: striatum ≫ hippocampus ≥ cortex > hypothalamus ≫ cerebellum. The 24-h tissue-to-cerebellum concentration ratios for 5-IBVM (5) were 3−4-fold higher for striatum, cortex, and hippocampus than the respective ratios for 6-IBVM (10). Neither 8-IBVM (16) nor 4‘-IBVM (17) exhibited selective retention in any of the brain regions examined. In the heart, only 5-IBVM (5) exhibited an atria-to-ventricles concentration ratio consistent with high peripheral cholinergic neuronal selectivity. The 7-IBVM (14) isomer exhibited an anomalous brain distribution pattern, marked by high and prolonged retention in the five brain regions, most notably the cerebellum. This isomer was screened for binding in a series of 26 different biological assays; 7-IBVM (14) exhibited affinity only for the σ-receptor with an IC50 of ∼30 nM. Drug-blocking studies suggested that brain retention of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors. Competitive binding studies using rat cortical homogenates gave IC50 values for binding to the vesamicol receptor of 2.5 nM for 5-IBVM (5), 4.8 nM for 6-IBVM (10), and 3.5 nM for 7-IBVM (14). Ex vivo autoradiography of rat brain after injection of (−)-5-[125I]IBVM ((−)-[125I]5) clearly delineated small cholinergic-rich areas such as basolateral amygdala, interpeduncular nucleus, and facial nuclei. Except for cortex, regional brain levels of (−)-5-[123I]IBVM ((−)-[123I]5) at 4 h exhibited a linear correlation (r = 0.99) with endogenous levels of choline acetyltransferase. Conclusion: Vesamicol receptor mapping of cholinergic nerve terminals in murine brain can be achieved with 5-IBVM (5) and less robustly with 6-IBVM (10), whereas the brain localization of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors.</description><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer Disease - physiopathology</subject><subject>Animals</subject><subject>Autoradiography</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Brain - cytology</subject><subject>Brain - metabolism</subject><subject>Brain - physiology</subject><subject>Brain Mapping</subject><subject>Cholinergic system</subject><subject>Female</subject><subject>Guinea Pigs</subject><subject>Humans</subject><subject>Iodine Radioisotopes</subject><subject>Isomerism</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred Strains</subject><subject>Neuromuscular Depolarizing Agents - chemical synthesis</subject><subject>Neuromuscular Depolarizing Agents - metabolism</subject><subject>Neurons - cytology</subject><subject>Neurons - metabolism</subject><subject>Neurons - physiology</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Organ Specificity</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperidines - chemical synthesis</subject><subject>Piperidines - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Cholinergic - analysis</subject><subject>Tetrahydronaphthalenes - chemical synthesis</subject><subject>Tetrahydronaphthalenes - metabolism</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EKtvCgR-A5AMgcQiMP-M9wopCpQWqsiDExXIcp_WSxMGTlI9fT8oue0LiNIfn0TujeQl5wOAZA86eb7ulglIafYssmOJQSAPyNlkAcF5wzcVdcoy4BQDBuDgiR6bUSrFyQa4_BXRd9KmlF8GHYUyZvnXDEPtLmhr6MrvY09VVamMf8mX09F2YcuqRfo_jFb1wdUwx1TMs6NpVoQ01PU8Yx5h619IzTF3I-Ccp9L_S9d9l98idxrUY7u_nCfl4-mqzelOs378-W71YF04yGIuay0oJCaXnRkkvlk5JbrRRmptlqAxAo7jzDTApKg26XgYthdDS1L6STIsT8mSXO-T0bQo42i6iD23r-pAmtKXhWir9f5EpbbiRchaf7kSfE2IOjR1y7Fz-aRnYmzLsoYzZfbgPnaou1Adz__2ZP9pzh961TXa9j3jQBDNSMDVrxU6LOIYfB-zyV6tLUSq7Of9gvwjY8M-G2Zu1j3e-82i3acpzFfiP834D7VOrNA</recordid><startdate>19960816</startdate><enddate>19960816</enddate><creator>Jung, Yong-Woon</creator><creator>Frey, Kirk A</creator><creator>Mulholland, G. Keith</creator><creator>del Rosario, Renato</creator><creator>Sherman, Phillip S</creator><creator>Raffel, David M</creator><creator>Van Dort, Marcian E</creator><creator>Kuhl, David E</creator><creator>Gildersleeve, David L</creator><creator>Wieland, Donald M</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19960816</creationdate><title>Vesamicol Receptor Mapping of Brain Cholinergic Neurons with Radioiodine- Labeled Positional Isomers of Benzovesamicol</title><author>Jung, Yong-Woon ; Frey, Kirk A ; Mulholland, G. Keith ; del Rosario, Renato ; Sherman, Phillip S ; Raffel, David M ; Van Dort, Marcian E ; Kuhl, David E ; Gildersleeve, David L ; Wieland, Donald M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a410t-d24b53407c2854c39a54286856289eb800f52acf0143b606d9e6433648dcb4163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer Disease - physiopathology</topic><topic>Animals</topic><topic>Autoradiography</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Brain - cytology</topic><topic>Brain - metabolism</topic><topic>Brain - physiology</topic><topic>Brain Mapping</topic><topic>Cholinergic system</topic><topic>Female</topic><topic>Guinea Pigs</topic><topic>Humans</topic><topic>Iodine Radioisotopes</topic><topic>Isomerism</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred Strains</topic><topic>Neuromuscular Depolarizing Agents - chemical synthesis</topic><topic>Neuromuscular Depolarizing Agents - metabolism</topic><topic>Neurons - cytology</topic><topic>Neurons - metabolism</topic><topic>Neurons - physiology</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Organ Specificity</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperidines - chemical synthesis</topic><topic>Piperidines - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Cholinergic - analysis</topic><topic>Tetrahydronaphthalenes - chemical synthesis</topic><topic>Tetrahydronaphthalenes - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jung, Yong-Woon</creatorcontrib><creatorcontrib>Frey, Kirk A</creatorcontrib><creatorcontrib>Mulholland, G. Keith</creatorcontrib><creatorcontrib>del Rosario, Renato</creatorcontrib><creatorcontrib>Sherman, Phillip S</creatorcontrib><creatorcontrib>Raffel, David M</creatorcontrib><creatorcontrib>Van Dort, Marcian E</creatorcontrib><creatorcontrib>Kuhl, David E</creatorcontrib><creatorcontrib>Gildersleeve, David L</creatorcontrib><creatorcontrib>Wieland, Donald M</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jung, Yong-Woon</au><au>Frey, Kirk A</au><au>Mulholland, G. Keith</au><au>del Rosario, Renato</au><au>Sherman, Phillip S</au><au>Raffel, David M</au><au>Van Dort, Marcian E</au><au>Kuhl, David E</au><au>Gildersleeve, David L</au><au>Wieland, Donald M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vesamicol Receptor Mapping of Brain Cholinergic Neurons with Radioiodine- Labeled Positional Isomers of Benzovesamicol</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1996-08-16</date><risdate>1996</risdate><volume>39</volume><issue>17</issue><spage>3331</spage><epage>3342</epage><pages>3331-3342</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Alzheimer's disease is characterized by progressive cerebral cholinergic neuronal degeneration. Radiotracer analogs of benzovesamicol, which bind with high affinity to the vesamicol receptor located on the uptake transporter of acetylcholine storage vesicles, may provide an in vivo marker of cholinergic neuronal integrity. Five positional isomers of racemic iodobenzovesamicol (4‘-, 5-, 6-, 7-, and 8-IBVM) were synthesized, exchange-labeled with iodine-125, and evaluated as possible in vivo markers for central cholinergic neurons. Only two isomers, 5-IBVM (5) and 6-IBVM (10), gave distribution patterns in mouse brain consistent with cholinergic innervation: striatum ≫ hippocampus ≥ cortex > hypothalamus ≫ cerebellum. The 24-h tissue-to-cerebellum concentration ratios for 5-IBVM (5) were 3−4-fold higher for striatum, cortex, and hippocampus than the respective ratios for 6-IBVM (10). Neither 8-IBVM (16) nor 4‘-IBVM (17) exhibited selective retention in any of the brain regions examined. In the heart, only 5-IBVM (5) exhibited an atria-to-ventricles concentration ratio consistent with high peripheral cholinergic neuronal selectivity. The 7-IBVM (14) isomer exhibited an anomalous brain distribution pattern, marked by high and prolonged retention in the five brain regions, most notably the cerebellum. This isomer was screened for binding in a series of 26 different biological assays; 7-IBVM (14) exhibited affinity only for the σ-receptor with an IC50 of ∼30 nM. Drug-blocking studies suggested that brain retention of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors. Competitive binding studies using rat cortical homogenates gave IC50 values for binding to the vesamicol receptor of 2.5 nM for 5-IBVM (5), 4.8 nM for 6-IBVM (10), and 3.5 nM for 7-IBVM (14). Ex vivo autoradiography of rat brain after injection of (−)-5-[125I]IBVM ((−)-[125I]5) clearly delineated small cholinergic-rich areas such as basolateral amygdala, interpeduncular nucleus, and facial nuclei. Except for cortex, regional brain levels of (−)-5-[123I]IBVM ((−)-[123I]5) at 4 h exhibited a linear correlation (r = 0.99) with endogenous levels of choline acetyltransferase. Conclusion: Vesamicol receptor mapping of cholinergic nerve terminals in murine brain can be achieved with 5-IBVM (5) and less robustly with 6-IBVM (10), whereas the brain localization of 7-IBVM (14) reflects high-affinity binding to both vesamicol and σ-receptors.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>8765517</pmid><doi>10.1021/jm9507486</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 1996-08, Vol.39 (17), p.3331-3342 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_78264566 |
source | MEDLINE; ACS Publications |
subjects | Alzheimer Disease - pathology Alzheimer Disease - physiopathology Animals Autoradiography Binding, Competitive Biological and medical sciences Brain - cytology Brain - metabolism Brain - physiology Brain Mapping Cholinergic system Female Guinea Pigs Humans Iodine Radioisotopes Isomerism Medical sciences Mice Mice, Inbred Strains Neuromuscular Depolarizing Agents - chemical synthesis Neuromuscular Depolarizing Agents - metabolism Neurons - cytology Neurons - metabolism Neurons - physiology Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Organ Specificity Pharmacology. Drug treatments Piperidines - chemical synthesis Piperidines - metabolism Rats Rats, Sprague-Dawley Receptors, Cholinergic - analysis Tetrahydronaphthalenes - chemical synthesis Tetrahydronaphthalenes - metabolism |
title | Vesamicol Receptor Mapping of Brain Cholinergic Neurons with Radioiodine- Labeled Positional Isomers of Benzovesamicol |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T04%3A36%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vesamicol%20Receptor%20Mapping%20of%20Brain%20Cholinergic%20Neurons%20with%20Radioiodine-%20Labeled%20Positional%20Isomers%20of%20Benzovesamicol&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Jung,%20Yong-Woon&rft.date=1996-08-16&rft.volume=39&rft.issue=17&rft.spage=3331&rft.epage=3342&rft.pages=3331-3342&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm9507486&rft_dat=%3Cproquest_cross%3E15682844%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15682844&rft_id=info:pmid/8765517&rfr_iscdi=true |